PARLIAMENTARY WRITTEN QUESTION
Pharmaceutical Price Regulation Scheme (8 May 2019)

To ask the Secretary of State for Health and Social Care, how much money was accrued to the public purse under the pharmaceutical price regulation scheme and (b) what proportion of that money was allocated to clinical commissioning groups between 2014 and 2019.

Asked by:
Sarah Champion (Labour)

Under the 2014 Pharmaceutical Price Regulation Scheme (PPRS), scheme members made payments to the Department. The 2014 PPRS has now delivered over £2.7 billion of PPRS payments. The following table shows the annual aggregate PPRS payments from 2014 until the end of the PPRS in December 2018. The 2019 Voluntary Scheme for Branded Medicines Pricing and Access is the current voluntary scheme.

Period	Aggregate PPRS payments
2014	£311 million
2015	£847 million
2016	£628 million
2017	£387 million
2018	£615 million

Further aggregate net sales and payment information can be found at the following link:

https://www.gov.uk/government/collections/pprs-quarterly-net-sales-and-payment-information

Each year, the Department estimates the England share of expected income from the PPRS which is then included within NHS England baseline financial allocations. Decisions on how to allocate funding across the health system is for NHS England to determine, in line with patient need.

Answered by:
Seema Kennedy (Conservative)
17 May 2019